title: Borderline tuberculoid leprosy coexisting with systemic lupus erythematosus.
authors.forename: P
authors.initials: P
authors.lastname: Zorbas
authors.forename: G
authors.initials: G
authors.lastname: Kontochristopoulos
authors.forename: I
authors.initials: I
authors.lastname: Detsi
authors.forename: E
authors.initials: E
authors.lastname: Apostolakis
authors.forename: N
authors.initials: N
authors.lastname: Kouris
authors.forename: A
authors.initials: A
authors.lastname: Katsambas
mesh_terms: D000890:Anti-Infective Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002939:Ciprofloxacin / Q000627:therapeutic use; D005260:Female; D016523:Foot Ulcer / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D015439:Leprosy, Borderline / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D008875:Middle Aged; D011239:Prednisolone / Q000627:therapeutic use
chemical_list: D000890:Anti-Infective Agents; D000893:Anti-Inflammatory Agents; D002939:Ciprofloxacin; D011239:Prednisolone